These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30298341)

  • 1. Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.
    Matsumoto Y; Fukushima S; Shimahara Y; Yamashita K; Kawamoto N; Kuroda K; Seguchi O; Yanase M; Fukushima N; Shimizu H; Kobayashi J; Fujita T
    J Artif Organs; 2019 Mar; 22(1):37-43. PubMed ID: 30298341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Driveline Fracture After Implantation of the HeartMate II Left Ventricular Assist Device: How Durable is Driveline Repair?
    Stulak JM; Schettle S; Haglund N; Dunlay S; Cowger J; Shah P; Aaronson KD; Pagani FD; Maltais S
    ASAIO J; 2017; 63(5):542-545. PubMed ID: 28125463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
    Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.
    Siegenthaler MP; Martin J; Pernice K; Doenst T; Sorg S; Trummer G; Friesewinkel O; Beyersdorf F
    Eur J Cardiothorac Surg; 2003 May; 23(5):748-54; discussion 754-5. PubMed ID: 12754028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between driveline features and driveline infection in left ventricular assist device selection.
    Imamura T; Murasawa T; Kawasaki H; Kashiwa K; Kinoshita O; Nawata K; Ono M
    J Artif Organs; 2017 Mar; 20(1):34-41. PubMed ID: 27448017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry.
    Dean D; Kallel F; Ewald GA; Tatooles A; Sheridan BC; Brewer RJ; Caldeira C; Farrar DJ; Akhter SA;
    J Heart Lung Transplant; 2015 Jun; 34(6):781-9. PubMed ID: 25735901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients.
    Wus L; Manning M; Entwistle JW
    Heart Lung; 2015; 44(3):225-9. PubMed ID: 25746483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
    Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
    Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple device to secure ventricular assist device driveline and prevent exit-site infection.
    Baronetto A; Centofanti P; Attisani M; Ricci D; Mussa B; Devotini R; Simonato E; Rinaldi M
    Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):415-7. PubMed ID: 24431003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.
    Camboni D; Zerdzitzki M; Hirt S; Tandler R; Weyand M; Schmid C
    Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):222-228. PubMed ID: 27702831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chlorhexidine gluconate intolerance on driveline infection during chronic HeartMate II left ventricular assist device support.
    Son AY; Stein LH; DeAnda A; Katz SD; Smith DE; Reyentovich A; Balsam LB
    Int J Artif Organs; 2017 Jan; 39(11):570-574. PubMed ID: 28085173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival.
    Singh A; Russo MJ; Valeroso TB; Anderson AS; Rich JD; Jeevanandam V; Akhter SA
    ASAIO J; 2014; 60(6):613-6. PubMed ID: 25072552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduce Driveline Trauma Through Stabilization and Exit Site Management: 30 Days Feasibility Results from the Multicenter RESIST Study.
    Stahovich M; Sundareswaran KS; Fox S; Hallinan W; Blood P; Chen L; Pamboukian SV; Chinn R; Farrar DJ; Pagani FD; Blue L
    ASAIO J; 2016; 62(3):240-5. PubMed ID: 27111738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series.
    Cikirikcioglu M; Ponchant K; Murith N; Meyer P; Yilmaz N; Huber C
    Int J Artif Organs; 2021 Nov; 44(11):912-916. PubMed ID: 34558333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
    Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
    Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.
    Bomholt T; Moser C; Sander K; Boesgaard S; Køber L; Olsen PS; Hansen PB; Mortensen SA; Gustafsson F
    Scand Cardiovasc J; 2011 Oct; 45(5):273-8. PubMed ID: 21539474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and prognostic impact of left ventricular assist device-associated infections.
    Tattevin P; Flécher E; Auffret V; Leclercq C; Boulé S; Vincentelli A; Dambrin C; Delmas C; Barandon L; Veniard V; Kindo M; Cardi T; Gaudard P; Rouvière P; Sénage T; Jacob N; Defaye P; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Savouré A; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Bernard L; Bourguignon T; Eschalier R; D'Ostrevy N; Jouan J; Varlet E; Vanhuyse F; Blangy H; Martins RP; Galand V
    Am Heart J; 2019 Aug; 214():69-76. PubMed ID: 31174053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Driveline Wound Care: Key to the Long-Term Use of Implantable Ventricular Assist Devices].
    Huang HC; Wang CH; Tsai FC
    Hu Li Za Zhi; 2019 Aug; 66(4):87-94. PubMed ID: 31342505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Success With Driveline Exit Site Relocation for Deep Driveline Infection in Left Ventricular Assist Device Patients.
    Balsam LB; Jacoby A; Louie E; Levine JP
    Innovations (Phila); 2017; 12(6):440-445. PubMed ID: 29232297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.